.svg){kind=small}
Market Insights Snapshot
In May 2026, Dablets operated as a single-category brand with Capsules at 100.0% of mix, while category sales declined 68.28% year over year and 18.49% month over month; the average price fell 18.15% YoY to $4.92, indicating price pressure concurrent with volume contraction. Within Colorado Capsules, the brand held rank 2 while experiencing a double-digit MoM slide of 18.49% and a sharper 68.28% YoY drop, implying that share maintenance is tied to a narrow franchise despite steep absolute declines. The pattern implies concentration risk: a fully concentrated mix magnifies volatility, so maintaining rank 2 alongside a 68% YoY decline suggests relative positioning is preserved locally but exposed to continued price-led compression.
The combination of 100% reliance on Capsules and an 18.15% YoY price reduction alongside an 18.49% MoM sales decline signals a reliance on discounting that is not translating into proportional volume resilience; holding rank 2 in Colorado while shrinking 68.28% YoY points to relative placement without category insulation. With no diversification offset, any further MoM softness of ~18% magnitude would compound the 24-month slide of 67.09%, implying that sustaining positioning will require either mix expansion or a price architecture that limits further erosion while preserving rank 2 in Capsules.
Competitive Landscape
Dablets ranks #2 in CO Capsules in May 2026, unchanged from #2 year over year, with its peak also at #2 in May 2026; this stability contrasts with Ripple (formerly Stillwater Brands) holding #1 both this year and last while growing sales by 17.3% YoY, and Stratos remaining at #3 year over year despite a 22.8% YoY sales lift, indicating that Dablets’ static #2 across 3 months and 12 months reflects a durable but capped position where share defense is steady yet upward mobility is constrained by a consistently entrenched #1 and a faster-growing #3.
Notable Products
Indica Sleep Tablets 10-Pack (100mg) posted the steepest contraction in May 2026 at -29.4% MoM while holding rank 2, whereas Sativa Energy Tablets 10-Pack (100mg) slipped -7.3% MoM but remained rank 1; two of the top two SKUs are Capsules, indicating a concentrated reliance on this format. With Sativa Energy Tablets 10-Pack (100mg) at rank 1 and Indica Sleep Tablets 10-Pack (100mg) at rank 2, the leadership stayed intact despite divergent momentum, and only one listed innovation, Max Relief Dablets 20-Pack (1000mg), showed no recorded movement or rank. Sativa’s smaller decline relative to Indica’s deeper fall suggests demand is tilting toward daytime utility within Capsules even as overall capsule velocity cools.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
